Treace Medical Concepts, Inc. Stock News

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Director James T. Treace sold 16,000 shares of the businesss stock in a transaction that occurred on Monday, November 22nd. The shares were sold at an average price of $18.52, for a total value of $296,320.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, []

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Director James T. Treace sold 17,000 shares of the companys stock in a transaction dated Wednesday, November 24th. The stock was sold at an average price of $17.83, for a total transaction of $303,110.00. The sale was disclosed in a document filed with the SEC, which is accessible through this []

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Director James T. Treace sold 16,000 shares of the companys stock in a transaction dated Monday, November 22nd. The stock was sold at an average price of $18.52, for a total value of $296,320.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can []

Related Stocks: TMCI ,

Treace Medical Concepts, Inc. (NASDAQ:TMCI) hit a new 52-week low on Wednesday . The stock traded as low as $17.04 and last traded at $17.52, with a volume of 331769 shares. The stock had previously closed at $18.09. Separately, SVB Leerink lowered their price target on Treace Medical Concepts from $38.00 to $32.00 and set []

MetLife Investment Management LLC bought a new position in Treace Medical Concepts, Inc. (NASDAQ:TMCI) in the second quarter, Holdings Channel.com reports. The firm bought 5,245 shares of the companys stock, valued at approximately $164,000. Several other hedge funds also recently bought and sold shares of the company. ArrowMark Colorado Holdings LLC bought a new position []

Treace Medical Concepts (NASDAQ:TMCI) and Venus Concept (NASDAQ:VERO) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, valuation and risk. Analyst Ratings This is a breakdown of current ratings and price targets for Treace []

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Director James T. Treace sold 25,000 shares of the businesss stock in a transaction dated Monday, November 15th. The stock was sold at an average price of $20.63, for a total transaction of $515,750.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this []

Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) hit a new 52-week low on Thursday following insider selling activity. The stock traded as low as $19.14 and last traded at $19.18, with a volume of 8441 shares. The stock had previously closed at $20.04. Specifically, Director James T. Treace sold 25,000 shares of the firms stock []

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Director James T. Treace sold 25,000 shares of the stock in a transaction on Monday, November 15th. The stock was sold at an average price of $20.63, for a total value of $515,750.00. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. NASDAQ []

Treace Medical Concepts' (TMCI) CEO John Treace on Q3 2021 Results - Earnings Call Transcript

PONTE VEDRA, Fla., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in th

PONTE VEDRA, Fla., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the

PONTE VEDRA, Fla., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the

PONTE VEDRA, Fla., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the